
Caroline’s Battle with PCNSL and the Role of Clinical Trials
Diagnosed with a rare and aggressive blood cancer affecting the brain, Caroline’s hope came through a groundbreaking clinical trial.
Raising Awareness on World Blood Cancer Day
Every 27 seconds, someone, somewhere in the world hears the life-changing words: “You have blood cancer.” This silent but devastating statistic reminds us that blood cancer does not discriminate — it can affect anyone, of any age, at any time. On World Blood Cancer Day, we stand in solidarity with patients, families, researchers, and healthcare professionals who are fighting to change that.
Blood cancer is complex and often aggressive diseases that can strike in infancy or in adulthood often without warning. While advances have been made in recent decades, for many, treatments are still harsh, options are limited, and the outcomes remain uncertain.
But there is hope. At Cure Leukaemia we are proud to play a vital role through funding Research Nurses to transform the landscape of blood cancer research and treatment, helping to bridge the gap between laboratory breakthroughs and bedside treatments — ensuring that patients benefit from innovation faster than ever before.
Why Awareness Matters
World Blood Cancer Day is not just a day of reflection — it is a call to action. With someone diagnosed every 27 seconds globally, the need for awareness, funding, and research has never been greater. By supporting organisations like Cure Leukaemia, we’re not only investing in science — we’re investing in people, in futures, and in the belief that a cure is not only possible but within reach.
Show Your Support
On this day, share the message, donate if you can, and above all — help make blood cancer visible.
Because blood cancer affects us all. But together, we can beat it.
Diagnosed with a rare and aggressive blood cancer affecting the brain, Caroline’s hope came through a groundbreaking clinical trial.
After a shock of Acute Lymphoblastic Leukaemia in late 2023, Neil Morris underwent intensive treatment and a life-saving stem cell transplant—made possible by a selfless donor from Germany, giving him a second chance at life.
From Entrepreneur Of The Year to AML Survivor. Moonii shares his AML story with us from when he was diagnosed aged 27.
Markas beat leukaemia at just 3 years old, and his story shows why the ATICUS Network is vital for giving children access to life-saving treatments.
Chief Executive James McLaughlin is lacing up his trainers once more for one final run, taking on his toughest test yet—running over 10 marathons in 14 days for a total of 270 miles with no rest days, running through 29 blood cancer centres across the UK where the charity supports through clinical trials networks
George Lineker, entrepreneur and long-time supporter of Cure Leukaemia, will once again take on the epic London 2 Paris cycling challenge this June, marking a decade since he first completed the ride in 2015, raising vital funds for Cure Leukaemia.